Pascoe Richard W 4
4 · SEELOS THERAPEUTICS, INC. · Filed Jan 6, 2022
Insider Transaction Report
Form 4
Pascoe Richard W
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-05+35,000→ 35,000 totalExercise: $1.56Exp: 2032-01-05→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]1/12th of the shares subject to the option shall vest on February 5, 2022, and 1/12th of the shares subject to the option shall vest monthly thereafter.